Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 36.21 ($0.47) and traded as low as GBX 36 ($0.47). Cambridge Cognition shares last traded at GBX 36.37 ($0.47), with a volume of 15,816 shares changing hands.
Cambridge Cognition Stock Down 6.8 %
The company has a current ratio of 0.65, a quick ratio of 0.96 and a debt-to-equity ratio of 92.53. The company has a market capitalization of £15.22 million, a price-to-earnings ratio of -9.66 and a beta of 0.72. The firm’s 50-day moving average price is GBX 42.42 and its 200 day moving average price is GBX 36.21.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Featured Articles
- Five stocks we like better than Cambridge Cognition
- Breakout Stocks: What They Are and How to Identify Them
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- Insider Buying Explained: What Investors Need to Know
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- What is the MACD Indicator and How to Use it in Your Trading
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
